MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial–mesenchymal transition

Abstract

Aim To explore the effect of miR-296-5p on the metastasis of nasopharyngeal carcinoma (NPC) cells and investigate the underlying mechanism. Methods The expressions of miR-296-5p in NPC tissues and cells were determined using GSE32920 database analysis and real-time PCR and miRNA microarray assays. An miR-296-5p mimic and inhibitor were transfected into NPC cells. Then, immunofluorescence imaging, scratch wound-healing, transwell migration and invasion assays were used to observe the effects of miR-296-5p on cell metastasis and invasion. Real-time PCR and western blotting were carried out to detect the expressions of genes and proteins related to epithelial–mesenchymal transition (EMT). A dual luciferase reporter assay was used to identify whether TGF-β is the target gene of miR-296-5p. Finally, TGF-β expression plasmids were transfected into NPC cells to verify the role of TGF-β in the miR-296-5p-mediated inhibition of nasopharyngeal carcinoma cell metastasis. Results Our results show that miR-296-5p inhibits the migratory and invasive capacities of NPC cells by targeting TGF-β, which suppresses EMT. Importantly, the miR-296-5p level was significantly lower in human NPC tissues than in adjacent normal tissues. It also negatively correlated with TGF-β and was significantly associated with the lymph node metastasis of patients with NPC. Conclusions Our findings show that miR-296-5p represses the EMT-related metastasis of NPC by targeting TGF-β. This provides new insight into the role of miR-296-5p in regulating NPC metastasis and invasiveness.

MiR-296-5p ameliorates deep venous thrombosis by inactivating S100A4

“…Therefore, miR-296-5p could regulate the EMT and change EMT-related gene expression through S100A4. In addition, some reports have indicated that miR-296-5p inhibits the EMT by targeting ZCCHC3 in osteosarcoma, 22 targeting TGF-b in nasopharyngeal carcinoma, 23 and targeting the Akt2/SNAI1 signaling pathway in oral squamous cell carcinoma. 24 Furthermore, S100A4 is a key regulator of vascular remodeling.…”

Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis

“…MicroRNAs (miRNAs/miRs) are small noncoding RNAs that regulate target genes by recognizing a complementary mRNA sequence and subsequently repressing its translation [ 8 ]. A growing number of studies have uncovered the key regulatory role of miRNAs in cancer metastasis [ 9 – 11 ]. On the basis of miRNA assay, we found that miR-5100 expression is increased in melanoma.…”

Photo-Assisted Robust Anti-Interference Self-Powered Biosensing of MicroRNA Based on Pt–S Bonds and the Inorganic–Organic Hybridization Strategy

“…MicroRNAs (miRNAs) are closely related to cell reproduction, growth, and apoptosis, which have been regarded as important cancer markers. − For example, miRNA-221 and miRNA-375 have been regarded as the important basis for the diagnosis and treatment of prostate cancer, , and miRNA141 is the biomarker for breast cancer, biliary tract cancer, and nasopharyngeal carcinoma . Thus, ultrasensitive detection of miRNAs is of great significance for early clinical diagnosis and biomedicine. , To date, numerous methods have been reported for miRNA assay, including real-time polymerase chain reaction (PCR), fluorescence, − electrochemistry, , and chemiluminescence . However, these methods still suffer from complex operation, high cost, and poor stability.…”